1
|
Chen Y, Zhao A, Lyu J, Hu Y, Yin Y, Qu J, Tong S, Li S. Association of Parasomnia Symptoms with Risk of Childhood Asthma and the Role of Preterm Birth. Nat Sci Sleep 2022; 14:1559-1573. [PMID: 36089999 PMCID: PMC9451036 DOI: 10.2147/nss.s356182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/23/2022] [Accepted: 06/20/2022] [Indexed: 11/23/2022] Open
Abstract
PURPOSE To examine whether parasomnia symptoms are associated with increased odds of childhood asthma and wheeze, and the role of preterm birth. PATIENTS AND METHODS The Shanghai Children's Allergy Study was cross-sectionally conducted in 31 kindergartens and 17 primary schools in Shanghai, China. After excluding the missing data of gestational week and child's age, this study included a total of 16,487 individuals with a mean age of 7.74 years and 52.4% of males. The association between parasomnia symptoms and wheeze/asthma was assessed by univariate and multivariate analyses. The interaction effects of parasomnias and preterm birth were primarily evaluated by P for multiplicative interaction, and the relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP), and synergy index (SI) were also measured. RESULTS Parasomnias, especially rapid eye movement (REM) parasomnia symptoms, were associated with an increased risk of childhood wheeze/asthma, and the interaction between parasomnia and preterm birth exhibited an excess risk of current wheeze (RERI, 1.43; 95% CI, 0.41-2.45) and ever asthma (RERI, 0.75; 95% CI, 0.01-1.50). In the stratification analyses, the combination of parasomnia symptoms and preterm birth had higher odds of wheeze/asthma. And the odds of current wheeze (OR, 4.55; 95% CI, 1.69-12.25; p=0.003) and ever asthma (OR, 6.17; 95% CI, 2.36-16.11; p<0.001) were much higher in cumulative parasomnia symptoms plus very preterm birth. And sensitive analyses were further conducted in populations without sleep disordered breathing (SDB), and an allergen test subgroup, yielding similar results. CONCLUSION Parasomnia symptoms are associated with increased odds of childhood wheeze/asthma, and the odds were even higher in premature population. The findings suggest that parasomnia symptoms, as a developmental sleep disorder, are supposed to be closely watched among children who have asthma or are at risk for asthma, and that preterm children deserve more attention.
Collapse
Affiliation(s)
- Yiting Chen
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
| | - Anda Zhao
- Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
| | - Jiajun Lyu
- Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China
| | - Yabin Hu
- Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
| | - Yong Yin
- Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
| | - Jiajie Qu
- Childcare Department, Shanghai Municipal Education Commission, Shanghai, People's Republic of China
| | - Shilu Tong
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.,Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.,School of Public Health, Institute of Environment and Population Health, Anhui Medical University, Hefei, People's Republic of China.,School of Public Health and Social Work, Queensland University of Technology, Brisbane, Australia
| | - Shenghui Li
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.,MOE-Shanghai Key Laboratory of Children's Environmental Health, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
| |
Collapse
|
2
|
Instanes JT, Klungsøyr K, Halmøy A, Fasmer OB, Haavik J. Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review. J Atten Disord 2018; 22:203-228. [PMID: 27664125 PMCID: PMC5987989 DOI: 10.1177/1087054716669589] [Citation(s) in RCA: 130] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
OBJECTIVE To systematically review, synthesize, and appraise available evidence, connecting adult ADHD with somatic disease. METHOD Embase, Psychinfo, and Medline databases were searched for studies published from 1994 to 2015 addressing adult ADHD and somatic comorbidity. Somatic conditions were classified according to International Classification of Diseases (ICD-10) codes. Levels of evidence were graded as inconclusive, tentative, or well documented. RESULTS Most of the 126 studies included in the qualitative synthesis were small and of modest quality. Obesity, sleep disorders, and asthma were well-documented comorbidities in adult ADHD. Tentative evidence was found for an association between adult ADHD and migraine and celiac disease. In a large health registry study, cardiovascular disease was not associated with adult ADHD. CONCLUSION There are few large systematic studies using standardized diagnostic criteria evaluating adult ADHD and somatic comorbidities. Significant associations are found between adult ADHD and several somatic diseases, and these are important to consider when assessing and treating either adult ADHD or the somatic diseases.
Collapse
Affiliation(s)
- Johanne Telnes Instanes
- Department of Biomedicine, University of Bergen, Norway,K.G. Jebsen Centre for Neuropsychiatric Disorders, University of Bergen, Norway,Johanne Telnes Instanes, K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, University of Bergen, Jonas Lies vei 91, N-5009 Bergen, Norway.
| | - Kari Klungsøyr
- Department of Global Public Health and Primary Care, University of Bergen, Norway,Norwegian Institute of Public Health, Bergen, Norway
| | - Anne Halmøy
- Department of Biomedicine, University of Bergen, Norway,K.G. Jebsen Centre for Neuropsychiatric Disorders, University of Bergen, Norway,Haukeland University Hospital, Bergen, Norway
| | - Ole Bernt Fasmer
- K.G. Jebsen Centre for Neuropsychiatric Disorders, University of Bergen, Norway,Haukeland University Hospital, Bergen, Norway,Department of Clinical Medicine, University of Bergen, Norway
| | - Jan Haavik
- Department of Biomedicine, University of Bergen, Norway,K.G. Jebsen Centre for Neuropsychiatric Disorders, University of Bergen, Norway,Haukeland University Hospital, Bergen, Norway
| |
Collapse
|
3
|
Güngen AC, Güngen B, Aydemir Y, Aras YG, Çoban H, Düzenli H. The relationship between restless legs syndrome and bronchial asthma. CLINICAL RESPIRATORY JOURNAL 2017; 12:1460-1465. [PMID: 28776939 DOI: 10.1111/crj.12684] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 03/20/2016] [Revised: 09/11/2016] [Accepted: 07/30/2017] [Indexed: 11/27/2022]
Abstract
INTRODUCTION Restless legs syndrome (RLS) is associated with sleep disorders. However, although sleep disturbance is prevalent in people with asthma, an insufficient number of studies have investigated the relationship between asthma and RLS. OBJECTIVES We aimed to determine the extent of the presence of RLS, and the factors related to RLS, in people with asthma. METHODS A total of 84 people with asthma and 51 healthy volunteers were enrolled. The diagnosis of RLS was made according to the criteria determined by the International Restless Legs Syndrome Study Group, and the Beck Depression and Beck Anxiety scales were used to assess both groups. The Asthma Control Test™(ACT) was carried out to determine asthma control status. RESULTS RLS was detected in 27 (32.1%) of the asthma group and in 8 (15.7%) of the control group. The frequency of RLS was significantly higher in the asthma group than in the control group (P = .034). Although no significant relationship was observed between the presence of RLS and the use of an inhaled steroid, use of a β2 agonist and age; a significant relationship was found between the presence of RLS and, ACT score, symptoms of depression and anxiety and gender (P < .05). CONCLUSIONS RLS was more frequent in people with asthma than in healthy individuals, and as asthma control decreased, frequency of RLS increased. It was concluded that it would be useful to evaluate people with asthma, particularly those with symptoms of depression and anxiety, with regard to RLS in order to address, and ultimately improve, their quality of life.
Collapse
Affiliation(s)
- Adil Can Güngen
- Department of Pulmonology, Sakarya University, Education and Research Hospital, Sakarya, Turkey
| | - Belma Güngen
- Department of Neurology, Sakarya University, Education and Research Hospital, Sakarya, Turkey
| | - Yusuf Aydemir
- Department of Pulmonology, Sakarya University, Education and Research Hospital, Sakarya, Turkey
| | - Yeşim Guzey Aras
- Department of Neurology, Sakarya University, Education and Research Hospital, Sakarya, Turkey
| | - Hikmet Çoban
- Department of Pulmonology, Sakarya University, Education and Research Hospital, Sakarya, Turkey
| | - Hasan Düzenli
- Department of Pulmonology, Sakarya University, Education and Research Hospital, Sakarya, Turkey
| |
Collapse
|
4
|
Elia J, Gai X, Xie HM, Perin JC, Geiger E, Glessner JT, D'arcy M, deBerardinis R, Frackelton E, Kim C, Lantieri F, Muganga BM, Wang L, Takeda T, Rappaport EF, Grant SFA, Berrettini W, Devoto M, Shaikh TH, Hakonarson H, White PS. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 2010; 15:637-46. [PMID: 19546859 PMCID: PMC2877197 DOI: 10.1038/mp.2009.57] [Citation(s) in RCA: 388] [Impact Index Per Article: 27.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a common and highly heritable disorder, but specific genetic factors underlying risk remain elusive. To assess the role of structural variation in ADHD, we identified 222 inherited copy number variations (CNVs) within 335 ADHD patients and their parents that were not detected in 2026 unrelated healthy individuals. Although no excess CNVs, either deletions or duplications, were found in the ADHD cohort relative to controls, the inherited rare CNV-associated gene set was significantly enriched for genes reported as candidates in studies of autism, schizophrenia and Tourette syndrome, including A2BP1, AUTS2, CNTNAP2 and IMMP2L. The ADHD CNV gene set was also significantly enriched for genes known to be important for psychological and neurological functions, including learning, behavior, synaptic transmission and central nervous system development. Four independent deletions were located within the protein tyrosine phosphatase gene, PTPRD, recently implicated as a candidate gene for restless legs syndrome, which frequently presents with ADHD. A deletion within the glutamate receptor gene, GRM5, was found in an affected parent and all three affected offspring whose ADHD phenotypes closely resembled those of the GRM5 null mouse. Together, these results suggest that rare inherited structural variations play an important role in ADHD development and indicate a set of putative candidate genes for further study in the etiology of ADHD.
Collapse
Affiliation(s)
- J Elia
- Department of Child and Adolescent Psychiatry, The Children's Hospital of Philadelphia Philadelphia, PA, USA,Department of Psychiatry, University of Pennsylvania School of Medicine Philadelphia, PA, USA
| | - X Gai
- Center for Biomedical Informatics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - H M Xie
- Center for Biomedical Informatics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - J C Perin
- Center for Biomedical Informatics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - E Geiger
- Division of Genetics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - J T Glessner
- Center for Applied Genomics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - M D'arcy
- Center for Biomedical Informatics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - R deBerardinis
- Department of Child and Adolescent Psychiatry, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - E Frackelton
- Center for Applied Genomics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - C Kim
- Center for Applied Genomics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - F Lantieri
- Division of Genetics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - B M Muganga
- Center for Biomedical Informatics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - L Wang
- Center for Biomedical Informatics, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - T Takeda
- Department of Child and Adolescent Psychiatry, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - E F Rappaport
- Joseph Stokes Jr Research Institute, The Children's Hospital of Philadelphia Philadelphia, PA, USA
| | - S F A Grant
- Division of Genetics, The Children's Hospital of Philadelphia Philadelphia, PA, USA,Center for Applied Genomics, The Children's Hospital of Philadelphia Philadelphia, PA, USA,Department of Pediatrics, University of Pennsylvania School of Medicine Philadelphia, PA, USA
| | - W Berrettini
- Department of Psychiatry, University of Pennsylvania School of Medicine Philadelphia, PA, USA
| | - M Devoto
- Division of Genetics, The Children's Hospital of Philadelphia Philadelphia, PA, USA,Department of Pediatrics, University of Pennsylvania School of Medicine Philadelphia, PA, USA,Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine Philadelphia, PA, USA,Dipartimento di Medicina Sperimentale, University La Sapienza Rome, Italy
| | - T H Shaikh
- Division of Genetics, The Children's Hospital of Philadelphia Philadelphia, PA, USA,Department of Pediatrics, University of Pennsylvania School of Medicine Philadelphia, PA, USA
| | - H Hakonarson
- Center for Applied Genomics, The Children's Hospital of Philadelphia Philadelphia, PA, USA,Department of Pediatrics, University of Pennsylvania School of Medicine Philadelphia, PA, USA,Division of Pulmonary Medicine, The Children's Hospital of Philadelphia Philadelphia, PA, USA,Author for correspondence:
| | - P S White
- Center for Biomedical Informatics, The Children's Hospital of Philadelphia Philadelphia, PA, USA,Department of Pediatrics, University of Pennsylvania School of Medicine Philadelphia, PA, USA,Division of Oncology, The Children's Hospital of Philadelphia Philadelphia, PA, USA,Author for correspondence:
| |
Collapse
|
5
|
Tikkinen KAO, Auvinen A, Johnson TM, Weiss JP, Keränen T, Tiitinen A, Polo O, Partinen M, Tammela TLJ. A systematic evaluation of factors associated with nocturia--the population-based FINNO study. Am J Epidemiol 2009; 170:361-8. [PMID: 19515794 PMCID: PMC2714949 DOI: 10.1093/aje/kwp133] [Citation(s) in RCA: 122] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
In a case-control study with prevalence sampling, the authors explored the correlates for nocturia and their population-level impact. In 2003–2004, questionnaires were mailed to 6,000 subjects (aged 18–79 years) randomly identified from the Finnish Population Register (62.4% participated; 53.7% were female). Questionnaires contained items on medical conditions, medications, lifestyle, sociodemographic and reproductive factors, urinary symptoms, and snoring. Nocturia was defined as ≥2 voids/night. In age-adjusted analyses, factors associated with nocturia were entered into a multivariate model. Backward elimination was used to select variables for the final model, with adjustment for confounding. Although numerous correlates were identified, none affected ≥50% of nocturia cases of both sexes. The factors with the greatest impact at the population level were (urinary) urgency (attributable number/1,000 subjects (AN) = 24), benign prostatic hyperplasia (AN = 19), and snoring (AN = 16) for men and overweight and obesity (AN = 40), urgency (AN = 24), and snoring (AN = 17) for women. Moreover, correlates included prostate cancer and antidepressant use for men, coronary artery disease and diabetes for women, and restless legs syndrome and obesity for both sexes. Although several correlates were identified, none accounted for a substantial proportion of the population burden, highlighting the multifactorial etiology of nocturia.
Collapse
Affiliation(s)
- Kari A O Tikkinen
- Clinical Research Institute HUCH Ltd/Tutkijatilat H3011, Haartmaninkatu 4, Helsinki, Finland.
| | | | | | | | | | | | | | | | | |
Collapse
|
6
|
|